MARKET

VCYT

VCYT

Veracyte
NASDAQ
36.19
+1.33
+3.82%
After Hours: 36.90 +0.71 +1.96% 17:18 02/06 EST
OPEN
35.67
PREV CLOSE
34.86
HIGH
36.50
LOW
34.71
VOLUME
1.20M
TURNOVER
--
52 WEEK HIGH
50.71
52 WEEK LOW
22.61
MARKET CAP
2.86B
P/E (TTM)
95.49
1D
5D
1M
3M
1Y
5Y
1D
Veracyte Inc. kündigt Veröffentlichung neuer Finanzergebnisse an
Reuters · 4d ago
Veracyte Inc. to Release Fourth Quarter and Full-Year 2025 Financial Results
Reuters · 4d ago
Press Release: Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
Dow Jones · 4d ago
Veracyte is Now Oversold (VCYT)
NASDAQ · 4d ago
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
Barchart · 4d ago
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Sarepta Therapeutics (SRPT) and Viridian Therapeutics (VRDN)
TipRanks · 4d ago
Cathie Wood's weekly recap: ramps up bets on JOBY, CRSP, pares ILMN, VCYT
Seeking Alpha · 6d ago
Weekly Report: what happened at VCYT last week (0126-0130)?
Weekly Report · 6d ago
More
About VCYT
Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and help patients to diagnose and treat cancer. The Veracyte Diagnostics Platform delivers cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and an evidence-generation engine, which drives durable reimbursement and guideline inclusion for its tests, along with new insights to support continued innovation and pipeline development. The Company offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna) and bladder cancer (Decipher Bladder). It has developed the noninvasive Percepta Nasal Swab test to help physicians accurately and quickly determine lung cancer risk. All of its tests are serviced through its own Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in South San Francisco, California, San Diego, California and Austin, Texas.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.